Carol Greider, Johns Hopkins researcher and a winner of the Nobel prize last week for her work on telomeres, submits to a Q&A with the New York Times. Asked about the timing of this prize -- Greider has for years been shortlisted as a potential laureate -- she responded, "I think it’s clear now that the basic science we did is important to understanding cancers, some human genetic diseases and the age associated degenerative diseases. The clinical relevance still needs to be understood in the medical community."
First the Nobel, Next the NYT Interview
Oct 13, 2009